Skip to main content
Top
Published in: Journal of Occupational Medicine and Toxicology 1/2021

Open Access 01-12-2021 | Hypersensitivity Pneumonitis | Review

Sooty bark disease of maples: the risk for hypersensitivity pneumonitis by fungal spores not only for woodman

Authors: Markus Braun, Doris Klingelhöfer, David A. Groneberg

Published in: Journal of Occupational Medicine and Toxicology | Issue 1/2021

Login to get access

Abstract

In the middle of the twentieth century, the from North America sooty bark disease (SBD) of maples was first discovered in England and has spread in the last decades in Central Europe, in particular. The trigger of SBD is the mould fungus Cryptostroma (C.) corticale. The most common infested maple is the sycamore, Acer pseudoplatanus, a common tree in woods and parks. The disease is characterised by peeling of the outer layer of the bark and brownish-black spores under the peeled off bark. These spores can cause maple bark disease (MBD) in humans, a hypersensitivity pneumonitis (HP) with similar symptoms like COPD, allergic asthma, influenza or flu-like infections and interstitial pneumonia. Persons who have intensive respectively occupational contact with infested trees or wood, e.g., woodman, foresters, sawyers or paper mill workers, are at risk in particular. Since C. corticale favours hot summers and host trees weakened by drought, SBD will increasingly spread in the future due to ongoing climate change. Consequently, the risk of developing MBD will increase, too. As with all HPs, e.g., farmer’s lung and pigeon breeder’s disease, the diagnosis of MBD is intricate because it has no clear distinguishing characteristics compared to other interstitial lung diseases. Therefore, the establishment of consistent diagnosis guidelines is required. For correct diagnosis and successful therapy, multidisciplinary expertise including pulmonologists, radiologists, pathologists and occupational physicians is recommended. If MBD is diagnosed in time, the removal of the triggering fungus or the infested maple wood leads to complete recovery in most cases. Chronic HP can lead to lung fibrosis and a total loss of lung function culminating in death. HP and, thus, MBD, is a disease with a very high occupational amount. To avoid contact with spores of C. corticale, persons working on infested wood or trees have to wear personal protective equipment. To protect the public, areas with infested maples have to be cordoned off, and the trees should be removed. This is also for impeding further spreading of the spores.
Literature
2.
go back to reference Ohman K, John H, Kenneth J, Kessler J, Meyer GC. Control of Cryptostroma corticale on stored sugar maple pulpwood. Phytopathology. 1969;59(6):871–3. Ohman K, John H, Kenneth J, Kessler J, Meyer GC. Control of Cryptostroma corticale on stored sugar maple pulpwood. Phytopathology. 1969;59(6):871–3.
3.
go back to reference Gregory PH, Peace TR, Waller S. Death of sycamore trees associated with an unidentified fungus. Nature. 1949;164:275.CrossRef Gregory PH, Peace TR, Waller S. Death of sycamore trees associated with an unidentified fungus. Nature. 1949;164:275.CrossRef
4.
go back to reference Gregory PH, Waller S. Cryptostroma corticale and sooty bark disease of sycamore (Acer pseudoplatanus). Trans Br Mycol Soc. 1951;34(4):579–97.CrossRef Gregory PH, Waller S. Cryptostroma corticale and sooty bark disease of sycamore (Acer pseudoplatanus). Trans Br Mycol Soc. 1951;34(4):579–97.CrossRef
5.
go back to reference Towey JW, Sweany HC, Huron WH. Severe bronchial asthma apparently due to fungus spores found in maple bark. J Amer Med Assoc. 1932;99:453–9.CrossRef Towey JW, Sweany HC, Huron WH. Severe bronchial asthma apparently due to fungus spores found in maple bark. J Amer Med Assoc. 1932;99:453–9.CrossRef
6.
go back to reference Emanuel DA, Lawton BR, Wenzel FJ. Maple-bark disease. Pneumonitis due to Coniosporium corticale. N Engl J Med. 1962;26:333–7.PubMedCrossRef Emanuel DA, Lawton BR, Wenzel FJ. Maple-bark disease. Pneumonitis due to Coniosporium corticale. N Engl J Med. 1962;26:333–7.PubMedCrossRef
7.
go back to reference Bevercombe GP, Rayner ADM. Population structure of Cryptostroma corticate, the causal fungusof sooty bark disease of sycamore. Plant Pathol. 1984;33(2):211–7.CrossRef Bevercombe GP, Rayner ADM. Population structure of Cryptostroma corticate, the causal fungusof sooty bark disease of sycamore. Plant Pathol. 1984;33(2):211–7.CrossRef
9.
go back to reference Plate HP, Schneider R. Ein Fall von asthmaartiger Allergie, verursacht durch den Pilz Cryptostroma corticale. Nachrichtenblatt des Deutschen Pflanzenschutzdienstes. 1965;17(7):100–1. Plate HP, Schneider R. Ein Fall von asthmaartiger Allergie, verursacht durch den Pilz Cryptostroma corticale. Nachrichtenblatt des Deutschen Pflanzenschutzdienstes. 1965;17(7):100–1.
10.
go back to reference Longa CMO, Vai N, Maresi G. Cryptostroma corticale in the northern Apennines (Italy). Phytopathol Mediterr. 2016;55(1):136–8. Longa CMO, Vai N, Maresi G. Cryptostroma corticale in the northern Apennines (Italy). Phytopathol Mediterr. 2016;55(1):136–8.
11.
go back to reference Cochard B., Crovadore J., Bovigny PY., Chablais R., Lefort F. First reports of Cryptostroma corticale causing sooty bark disease in Acer sp. in Canton Geneva, Switzerland. New Disease Reports. 2015;31(8). Cochard B., Crovadore J., Bovigny PY., Chablais R., Lefort F. First reports of Cryptostroma corticale causing sooty bark disease in Acer sp. in Canton Geneva, Switzerland. New Disease Reports. 2015;31(8).
12.
go back to reference Bencheva S. First report of Cryptostroma corticale (Ellis & Everh.) P.H. Greg. & S. Waller on Acer platanoides L. in Bulgaria. Silva Balcanica. 2014;15(2):101–4. Bencheva S. First report of Cryptostroma corticale (Ellis & Everh.) P.H. Greg. & S. Waller on Acer platanoides L. in Bulgaria. Silva Balcanica. 2014;15(2):101–4.
13.
go back to reference Koukol O, Kelnarová I, Cerný K. Recent observations of sooty bark disease of sycamore maple in Prague (Czech Republic) and the phylogenetic placement of Cryptostroma corticale. For Pathol. 2015;45(1):21–7.CrossRef Koukol O, Kelnarová I, Cerný K. Recent observations of sooty bark disease of sycamore maple in Prague (Czech Republic) and the phylogenetic placement of Cryptostroma corticale. For Pathol. 2015;45(1):21–7.CrossRef
14.
go back to reference Kelnarova I, Cerny K, Zahradnik D, Koukol O. Widespread latent infection of Cryptostroma corticale in asymptomatic Acer pseudoplatanus as a risk for urban plantations. Forest Pathology. 2017;47(4). Kelnarova I, Cerny K, Zahradnik D, Koukol O. Widespread latent infection of Cryptostroma corticale in asymptomatic Acer pseudoplatanus as a risk for urban plantations. Forest Pathology. 2017;47(4).
15.
go back to reference Emanuel DA, Wenzel FJ, Lawton BR. Pneumonitis due to Cryptostroma corticale (maple-bark disease). N Engl J Med. 1966;274(25):1413–8.PubMedCrossRef Emanuel DA, Wenzel FJ, Lawton BR. Pneumonitis due to Cryptostroma corticale (maple-bark disease). N Engl J Med. 1966;274(25):1413–8.PubMedCrossRef
17.
go back to reference Rusanen M, Myking T. EUFORGEN technical guidelines for genetic conserva-tion and use for sycamore (Acerpseudoplatanus). Rome: International Plant Genetic Resources Institute; 2003. Rusanen M, Myking T. EUFORGEN technical guidelines for genetic conserva-tion and use for sycamore (Acerpseudoplatanus). Rome: International Plant Genetic Resources Institute; 2003.
18.
go back to reference Ellis JB, Everhart BM. New species of hyphomycetes fungi. Journal of Mycology. 1889;5(2):68–72. Ellis JB, Everhart BM. New species of hyphomycetes fungi. Journal of Mycology. 1889;5(2):68–72.
20.
go back to reference Abbey SD. The morphology and physiology of Cryptostroma corticale. Loughborough, United Kingdom: Loughborough University; 1978. Abbey SD. The morphology and physiology of Cryptostroma corticale. Loughborough, United Kingdom: Loughborough University; 1978.
21.
go back to reference Abbey SD, Stretton RJ. Electron microscope study of Cryptostroma corticale. Cytobios. 1978;21(81):45–55.PubMed Abbey SD, Stretton RJ. Electron microscope study of Cryptostroma corticale. Cytobios. 1978;21(81):45–55.PubMed
22.
go back to reference Cech TL. Sooty bark disease endangers stands of sycamore maple in Lower Austria. Forstschutz Aktuell. 2019;65:23–8. Cech TL. Sooty bark disease endangers stands of sycamore maple in Lower Austria. Forstschutz Aktuell. 2019;65:23–8.
23.
go back to reference Dickenson S, Wheeler BEJ. Effects of temperature, and water-stress in sycamore, on growth of Cryptostroma-Corticale. Trans Br Mycol Soc. 1981;76(Apr):181–5.CrossRef Dickenson S, Wheeler BEJ. Effects of temperature, and water-stress in sycamore, on growth of Cryptostroma-Corticale. Trans Br Mycol Soc. 1981;76(Apr):181–5.CrossRef
24.
go back to reference Young CWT. Sooty bark disease of sycamore. Arboricultural Leaflet. London: Department of the Environment. H.M.S.O; 1978. p. 8. Young CWT. Sooty bark disease of sycamore. Arboricultural Leaflet. London: Department of the Environment. H.M.S.O; 1978. p. 8.
26.
go back to reference Lonsdale D, MacAskill GA, Rose DR, Tilbury C, Thorpe KV. The Health of Non-Woodland Trees in England during 1999 and 2000. Arboriculture Research and Information Note; 2003. Lonsdale D, MacAskill GA, Rose DR, Tilbury C, Thorpe KV. The Health of Non-Woodland Trees in England during 1999 and 2000. Arboriculture Research and Information Note; 2003.
27.
go back to reference Peace TR. Sooty bark disease of sycamorea disease in eclipse. Quarterly Jourool of Forestry. 1955;49:197–204. Peace TR. Sooty bark disease of sycamorea disease in eclipse. Quarterly Jourool of Forestry. 1955;49:197–204.
34.
go back to reference Wenzel FJ, Emanuel DA. The epidemiology of maple bark disease. Arch Environ Health. 1967;14(3):385–9.PubMedCrossRef Wenzel FJ, Emanuel DA. The epidemiology of maple bark disease. Arch Environ Health. 1967;14(3):385–9.PubMedCrossRef
35.
go back to reference Tewksbury DA, Wenzel FJ, Emanuel DA. An immunological study of maple bark disease. Clin Exp Immunol. 1968;3(8):857–63.PubMedPubMedCentral Tewksbury DA, Wenzel FJ, Emanuel DA. An immunological study of maple bark disease. Clin Exp Immunol. 1968;3(8):857–63.PubMedPubMedCentral
36.
go back to reference Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012;186(4):314–24.PubMedCrossRef Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012;186(4):314–24.PubMedCrossRef
38.
go back to reference Sennekamp J, Lehmann E, Joest M. Work-related extrinsic allergic alveolitis. ASU Arbeitsmed Sozialmed Umweltmed. 2015;50:38–52. Sennekamp J, Lehmann E, Joest M. Work-related extrinsic allergic alveolitis. ASU Arbeitsmed Sozialmed Umweltmed. 2015;50:38–52.
39.
go back to reference Bourke SJ, Dalphin JC, Boyd G, McSharry C, Baldwin CI, Calvert JE. Hypersensitivity pneumonitis: current concepts. Eur Respir J Suppl. 2001;32:81s–92s.PubMed Bourke SJ, Dalphin JC, Boyd G, McSharry C, Baldwin CI, Calvert JE. Hypersensitivity pneumonitis: current concepts. Eur Respir J Suppl. 2001;32:81s–92s.PubMed
40.
go back to reference Nogueira R, Melo N, Novais EBH, Martins N, Delgado L, Morais A, et al. Hypersensitivity pneumonitis: antigen diversity and disease implications. Pulmonology. 2019;25(2):97–108.PubMedCrossRef Nogueira R, Melo N, Novais EBH, Martins N, Delgado L, Morais A, et al. Hypersensitivity pneumonitis: antigen diversity and disease implications. Pulmonology. 2019;25(2):97–108.PubMedCrossRef
41.
go back to reference Selman M. Hypersensitivity pneumonitis. In: Schwarz M, King Jr TE, editors. Interstitial lung disease. Shelton, CT, USA: People’s Medical Publishing House; 2011. p. 597–625. Selman M. Hypersensitivity pneumonitis. In: Schwarz M, King Jr TE, editors. Interstitial lung disease. Shelton, CT, USA: People’s Medical Publishing House; 2011. p. 597–625.
42.
43.
go back to reference Leone PM, Richeldi L. Current diagnosis and Management of Hypersensitivity Pneumonitis. Tuberc Respir Dis (Seoul). 2020;83(2):122–31.CrossRef Leone PM, Richeldi L. Current diagnosis and Management of Hypersensitivity Pneumonitis. Tuberc Respir Dis (Seoul). 2020;83(2):122–31.CrossRef
44.
go back to reference Lacasse Y, Girard M, Cormier Y. Recent advances in hypersensitivity pneumonitis. Chest. 2012;142(1):208–17.PubMedCrossRef Lacasse Y, Girard M, Cormier Y. Recent advances in hypersensitivity pneumonitis. Chest. 2012;142(1):208–17.PubMedCrossRef
45.
go back to reference Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, et al. Hypersensitivity Pneumonitis: A Comprehensive Review. J Investig Allergol Clin Immunol. 2015;25(4):237–50 quiz follow 50.PubMed Spagnolo P, Rossi G, Cavazza A, Bonifazi M, Paladini I, Bonella F, et al. Hypersensitivity Pneumonitis: A Comprehensive Review. J Investig Allergol Clin Immunol. 2015;25(4):237–50 quiz follow 50.PubMed
46.
go back to reference Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2006;30(2):201–8.PubMedCrossRef Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2006;30(2):201–8.PubMedCrossRef
47.
go back to reference Jedrych ME, Szturmowicz M, Bestry I, Kus J. Hypersensitivity pneumonitis: diagnostic criteria, treatment, prognosis and prevention. Med Pr. 2016;67(4):517–27.PubMedCrossRef Jedrych ME, Szturmowicz M, Bestry I, Kus J. Hypersensitivity pneumonitis: diagnostic criteria, treatment, prognosis and prevention. Med Pr. 2016;67(4):517–27.PubMedCrossRef
48.
go back to reference Costabel U, Miyazaki Y, Pardo A, Koschel D, Bonella F, Spagnolo P, et al. Hypersensitivity pneumonitis. Nat Rev Dis Primers. 2020;6(1):65.PubMedCrossRef Costabel U, Miyazaki Y, Pardo A, Koschel D, Bonella F, Spagnolo P, et al. Hypersensitivity pneumonitis. Nat Rev Dis Primers. 2020;6(1):65.PubMedCrossRef
49.
go back to reference Fernandez Perez ER, Koelsch TL, Leone PM, Groshong SD, Lynch DA, Brown KK. Clinical decision-making in hypersensitivity pneumonitis: diagnosis and management. Semin Respir Crit Care Med. 2020;41(2):214–28.PubMedCrossRef Fernandez Perez ER, Koelsch TL, Leone PM, Groshong SD, Lynch DA, Brown KK. Clinical decision-making in hypersensitivity pneumonitis: diagnosis and management. Semin Respir Crit Care Med. 2020;41(2):214–28.PubMedCrossRef
50.
go back to reference Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG, Pereira CAC. Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis. Thorax. 2018;73(4):391–2.PubMedCrossRef Gimenez A, Storrer K, Kuranishi L, Soares MR, Ferreira RG, Pereira CAC. Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis. Thorax. 2018;73(4):391–2.PubMedCrossRef
51.
go back to reference Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017;196(6):680–9.PubMedCrossRef Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017;196(6):680–9.PubMedCrossRef
52.
go back to reference Lacasse Y, Selman M, Costabel U, Dalphin JC, Morell F, Erkinjuntti-Pekkanen R, et al. Classification of hypersensitivity pneumonitis: a hypothesis. Int Arch Allergy Immunol. 2009;149(2):161–6.PubMedCrossRef Lacasse Y, Selman M, Costabel U, Dalphin JC, Morell F, Erkinjuntti-Pekkanen R, et al. Classification of hypersensitivity pneumonitis: a hypothesis. Int Arch Allergy Immunol. 2009;149(2):161–6.PubMedCrossRef
53.
go back to reference Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202(3):e36–69.PubMedPubMedCentralCrossRef Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020;202(3):e36–69.PubMedPubMedCentralCrossRef
54.
go back to reference Wuyts W, Sterclova M, Vasakova M. Pitfalls in diagnosis and management of hypersensitivity pneumonitis. Curr Opin Pulm Med. 2015;21(5):490–8.PubMedCrossRef Wuyts W, Sterclova M, Vasakova M. Pitfalls in diagnosis and management of hypersensitivity pneumonitis. Curr Opin Pulm Med. 2015;21(5):490–8.PubMedCrossRef
57.
go back to reference Solaymani-Dodaran M, West J, Smith C, Hubbard R. Extrinsic allergic alveolitis: incidence and mortality in the general population. QJM. 2007;100(4):233–7.PubMedCrossRef Solaymani-Dodaran M, West J, Smith C, Hubbard R. Extrinsic allergic alveolitis: incidence and mortality in the general population. QJM. 2007;100(4):233–7.PubMedCrossRef
58.
go back to reference Fernandez Perez ER, Kong AM, Raimundo K, Koelsch TL, Kulkarni R, Cole AL. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Ann Am Thorac Soc. 2018;15(4):460–9.PubMedCrossRef Fernandez Perez ER, Kong AM, Raimundo K, Koelsch TL, Kulkarni R, Cole AL. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Ann Am Thorac Soc. 2018;15(4):460–9.PubMedCrossRef
59.
go back to reference Rittig AH, Hilberg O, Ibsen R, Lokke A. Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study. ERJ Open Res. 2019;5(4). Rittig AH, Hilberg O, Ibsen R, Lokke A. Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study. ERJ Open Res. 2019;5(4).
60.
go back to reference Hirschmann JV, Pipavath SN, Godwin JD. Hypersensitivity pneumonitis: a historical, clinical, and radiologic review. Radiographics. 2009;29(7):1921–38.PubMedCrossRef Hirschmann JV, Pipavath SN, Godwin JD. Hypersensitivity pneumonitis: a historical, clinical, and radiologic review. Radiographics. 2009;29(7):1921–38.PubMedCrossRef
61.
go back to reference Baur X, Fischer A, Budnik LT. Spotlight on the diagnosis of extrinsic allergic alveolitis (hypersensitivity pneumonitis). J Occup Med Toxicol. 2015;10:15.PubMedPubMedCentralCrossRef Baur X, Fischer A, Budnik LT. Spotlight on the diagnosis of extrinsic allergic alveolitis (hypersensitivity pneumonitis). J Occup Med Toxicol. 2015;10:15.PubMedPubMedCentralCrossRef
62.
go back to reference Quirce S, Vandenplas O, Campo P, Cruz MJ, de Blay F, Koschel D, et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016;71(6):765–79.PubMedCrossRef Quirce S, Vandenplas O, Campo P, Cruz MJ, de Blay F, Koschel D, et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016;71(6):765–79.PubMedCrossRef
63.
go back to reference Bellanger AP, Reboux G, Rouzet A, Barrera C, Rocchi S, Scherer E, et al. Hypersensitivity pneumonitis: a new strategy for serodiagnosis and environmental surveys. Resp Med. 2019;150:101–6.CrossRef Bellanger AP, Reboux G, Rouzet A, Barrera C, Rocchi S, Scherer E, et al. Hypersensitivity pneumonitis: a new strategy for serodiagnosis and environmental surveys. Resp Med. 2019;150:101–6.CrossRef
64.
go back to reference Budnik LT, Adam B, Albin M, Banelli B, Baur X, Belpoggi F, et al. Diagnosis, monitoring and prevention of exposure-related non-communicable diseases in the living and working environment: DiMoPEx-project is designed to determine the impacts of environmental exposure on human health. J Occup Med Toxicol. 2018;13:6.PubMedPubMedCentralCrossRef Budnik LT, Adam B, Albin M, Banelli B, Baur X, Belpoggi F, et al. Diagnosis, monitoring and prevention of exposure-related non-communicable diseases in the living and working environment: DiMoPEx-project is designed to determine the impacts of environmental exposure on human health. J Occup Med Toxicol. 2018;13:6.PubMedPubMedCentralCrossRef
65.
go back to reference Shepherd GM, Michelis MA, Macris NT, Smith JP. Hypersensitivity pneumonitis in an orchid grower associated with sensitivity to the fungus Cryptostroma corticale. Ann Allergy. 1989;62(6):522–5.PubMed Shepherd GM, Michelis MA, Macris NT, Smith JP. Hypersensitivity pneumonitis in an orchid grower associated with sensitivity to the fungus Cryptostroma corticale. Ann Allergy. 1989;62(6):522–5.PubMed
66.
go back to reference Grüner J, Kist K, Klaiber F, Wanner L. Damage of sycamore caused by fungal infections with Cryptostroma corticale in Baden-Württemberg. Julius-Kühn-Archiv. 2018;461:466–7. Grüner J, Kist K, Klaiber F, Wanner L. Damage of sycamore caused by fungal infections with Cryptostroma corticale in Baden-Württemberg. Julius-Kühn-Archiv. 2018;461:466–7.
Metadata
Title
Sooty bark disease of maples: the risk for hypersensitivity pneumonitis by fungal spores not only for woodman
Authors
Markus Braun
Doris Klingelhöfer
David A. Groneberg
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Occupational Medicine and Toxicology / Issue 1/2021
Electronic ISSN: 1745-6673
DOI
https://doi.org/10.1186/s12995-021-00292-5

Other articles of this Issue 1/2021

Journal of Occupational Medicine and Toxicology 1/2021 Go to the issue